Oakworth Capital’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$29.5K Hold
250
﹤0.01% 534
2025
Q4
$41K Hold
250
﹤0.01% 463
2025
Q3
$33.4K Hold
250
﹤0.01% 489
2025
Q2
$31.1K Hold
250
﹤0.01% 398
2025
Q1
$31.8K Hold
250
﹤0.01% 413
2024
Q4
$36K Hold
250
﹤0.01% 396
2024
Q3
$37.2K Hold
250
﹤0.01% 392
2024
Q2
$31.5K Hold
250
﹤0.01% 399
2024
Q1
$46K Hold
250
﹤0.01% 325
2023
Q4
$45K Hold
250
﹤0.01% 331
2023
Q3
$39.8K Hold
250
﹤0.01% 324
2023
Q2
$35.4K Hold
250
﹤0.01% 344
2023
Q1
$42.1K Hold
250
﹤0.01% 315
2022
Q4
$42.3K Hold
250
﹤0.01% 301
2022
Q3
$47K Hold
250
0.01% 300
2022
Q2
$41K Hold
250
﹤0.01% 319
2022
Q1
$47K Hold
250
﹤0.01% 313
2021
Q4
$66K Hold
250
0.01% 305
2021
Q3
$72K Buy
+250
New +$64.1K 0.01% 274
2018
Q4
Sell
-1,500
Closed -$83K 596
2018
Q3
$83K Hold
1,500
0.02% 250
2018
Q2
$71K Hold
1,500
0.01% 257
2018
Q1
$56K Hold
1,500
0.01% 269
2017
Q4
$53K Hold
1,500
0.01% 280
2017
Q3
$65K Hold
1,500
0.02% 269
2017
Q2
$62K Hold
1,500
0.02% 265
2017
Q1
$53K Hold
1,500
0.02% 271
2016
Q4
$48K Hold
1,500
0.02% 268
2016
Q3
$45K Hold
1,500
0.02% 267
2016
Q2
$36K Hold
1,500
0.01% 287
2016
Q1
$40K Buy
+1,500
New +$36.7K 0.02% 232

Other funds holding RGEN

Oakworth Capital's RGEN Position: Q1 2026 in Review

Oakworth Capital held its Repligen (RGEN) position steady in Q1 2026 at 250 shares worth $29.5K. The position accounts for ﹤0.01% of the portfolio, ranked #534.

Oakworth Capital first reported a position in RGEN in Q1 2016 and has held it in 30 quarters since. The position peaked at $83K in Q3 2018. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Oakworth Capital held 250 shares of Repligen worth $29.5K as of Q1 2026.
  • Oakworth Capital left its Repligen share count unchanged in Q1 2026.
  • Repligen made up ﹤0.01% of Oakworth Capital's portfolio in Q1 2026, its #534 holding.
  • Oakworth Capital first reported a position in Repligen in Q1 2016 and has held it in 30 quarters since.
  • Oakworth Capital's Repligen position peaked at $83K in Q3 2018.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Oakworth Capital's 13F filing for Q1 2026, filed 24 Apr 2026.